Harnessing Allogeneic NK Cells: Non-Engineered, Engineered, & Combination Approaches in Oncology & Autoimmune Disorders
Time: 1:15 pm
day: Day Two - Track A PM
Details:
- Clinical development of non-engineered NK cells in hematological malignancies
- Preclinical innovations in engineered and combination NK cell therapies for oncology and autoimmunity
